Income Statement Enzymatica AB

Stocks

ENZY

SE0003943620

Pharmaceuticals

Market Closed - Nasdaq Stockholm 12:00:00 2026-10-07 EDT			5-day change	1st Jan Change
1.700 ^SEK	-1.73%		-0.58%	-10.53%

09-02	Enzymatica CEO buys additional shares	FW
09-01	Enzymatica CEO buys 33 384 shares	FW

3f6cce3e4f438f0b0.8GE-B0d_-QMbqeipGkOWmFZRJLhWi2Xaj7glhsB-PLI.tFZESgQJrGxK4o_weyW7-RQUEMAbxS-7uIlk7o4fVf-YPkptMBucVin9qQ

Published financial data: ENZYMATICA AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (SEK)	2022 (SEK)	2023 (SEK)	2024 (SEK)	2025 (SEK)
Revenues	57.24M	48.95M	50.9M	45.58M	53.9M
Total Revenues	57.24M	48.95M	50.9M	45.58M	53.9M
Cost of Goods Sold, Total	23.89M	20.49M	19.04M	14.86M	20.78M
Gross Profit	33.35M	28.45M	31.86M	30.72M	33.12M
Selling General & Admin Expenses, Total	55.42M	71.5M	67.78M	68.02M	69.67M
R&D Expenses	24.21M	26.5M	15.31M	15.46M	15.66M
Other Operating Expenses	-1.04M	-1.32M	-3.17M	-706K	-839K
Other Operating Expenses, Total	78.6M	96.67M	79.92M	82.77M	84.49M
Operating Income	-45.25M	-68.22M	-48.06M	-52.05M	-51.37M
Interest Expense, Total	-889K	-997K	-2.09M	-1.72M	-74K
Interest And Investment Income	3K	34K	338K	523K	640K
Net Interest Expenses	-886K	-963K	-1.75M	-1.2M	566K
Currency Exchange Gains (Loss)	433K	434K	93K	-83K	-1.04M
Other Non Operating Income (Expenses)	-	1K	1K	-1K	2K
EBT, Excl. Unusual Items	-45.7M	-68.75M	-49.72M	-53.34M	-51.84M
Merger & Related Restructuring Charges	-	-	-	-	-
Asset Writedown	-	-	-	-	-
EBT, Incl. Unusual Items	-45.7M	-68.75M	-49.72M	-53.34M	-51.84M
Income Tax Expense	-307K	-89K	9K	-159K	51K
Earnings From Continuing Operations	-45.39M	-68.66M	-49.73M	-53.18M	-51.89M
Net Income to Company	-45.39M	-68.66M	-49.73M	-53.18M	-51.89M
Net Income - (IS)	-45.39M	-68.66M	-49.73M	-53.18M	-51.89M
Net Income to Common Incl Extra Items	-45.39M	-68.66M	-49.73M	-53.18M	-51.89M
Net Income to Common Excl. Extra Items	-45.39M	-68.66M	-49.73M	-53.18M	-51.89M
Per Share Items
Net EPS - Basic	-0.31	-0.44	-0.3	-0.28	-0.21
Basic EPS - Continuing Operations	-0.31	-0.44	-0.3	-0.28	-0.21
Basic Weighted Average Shares Outstanding	147M	154M	164M	193M	243M
Net EPS - Diluted	-0.31	-0.44	-0.3	-0.28	-0.21
Diluted EPS - Continuing Operations	-0.31	-0.44	-0.3	-0.28	-0.21
Diluted Weighted Average Shares Outstanding	147M	154M	164M	193M	243M
Normalized Basic EPS	-0.19	-0.28	-0.19	-0.17	-0.13
Normalized Diluted EPS	-0.19	-0.28	-0.19	-0.17	-0.13
Supplemental Items
EBITDA	-43.1M	-65.08M	-44.96M	-49.22M	-48.83M
EBITA	-44.49M	-67.39M	-47.56M	-51.59M	-51.04M
EBIT	-45.25M	-68.22M	-48.06M	-52.05M	-51.37M
EBITDAR	-42.28M	-63.8M	-43.56M	-47.7M	-46.77M
Effective Tax Rate - (Ratio)	0.67	0.13	-0.02	0.3	-0.1
Total Deferred Taxes	-307K	-89K	9K	-159K	51K
Normalized Net Income	-28.56M	-42.97M	-31.07M	-33.34M	-32.4M
Interest on Long-Term Debt	55K	62K	78K	75K	70K
Supplemental Operating Expense Items
Selling and Marketing Expenses	22.65M	32.78M	28.37M	26.73M	27.44M
General and Administrative Expenses	32.77M	38.72M	39.41M	41.28M	42.24M
Research And Development Expense From Footnotes	27.32M	29.58M	17.2M	17.03M	17.24M
Net Rental Expense, Total	829K	1.28M	1.4M	1.52M	2.06M
Imputed Operating Lease Interest Expense	674K	817K	1.16M	2.07M	755K
Imputed Operating Lease Depreciation	155K	461K	242K	-547K	1.3M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: December	2021 (SEK)	2022 (SEK)	2023 (SEK)	2024 (SEK)	2025 (SEK)
Assets
Cash And Equivalents	31.62M	50.69M	8.37M	75.21M	33.13M
Total Cash And Short Term Investments	31.62M	50.69M	8.37M	75.21M	33.13M
Accounts Receivable, Total	16.32M	14.23M	11.34M	12.09M	10M
Other Receivables	3.75M	3.48M	3.13M	3.31M	2.15M
Notes Receivable	-	-	-	-	-
Total Receivables	20.07M	17.7M	14.47M	15.4M	12.15M
Inventory	12.44M	11.51M	11.5M	16.71M	18.92M
Prepaid Expenses	651K	4.94M	4.45M	4.68M	826K
Total Current Assets	64.78M	84.85M	38.78M	112M	65.02M
Gross Property Plant And Equipment	21.1M	24.97M	27.6M	28.79M	25.78M
Accumulated Depreciation	-5.94M	-8.57M	-11.12M	-14.39M	-15.42M
Net Property Plant And Equipment	15.16M	16.4M	16.48M	14.4M	10.36M
Long-term Investments	-	-	-	-	-
Goodwill	63.21M	63.21M	63.21M	63.21M	63.21M
Other Intangibles, Total	1.99M	1.62M	1.12M	660K	328K
Deferred Tax Assets Long-Term	2.12M	2.32M	2.32M	2.64M	2.41M
Deferred Charges Long-Term	9.79M	6.02M	4M	2.33M	646K
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	157M	174M	126M	195M	142M
Liabilities
Accounts Payable, Total	7.61M	6.67M	7.37M	9.81M	8.75M
Accrued Expenses, Total	19.24M	17.08M	9.51M	5.44M	5.86M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	266K	-	-	-	-
Current Portion of Leases	1.24M	1.2M	1.22M	1.18M	1.02M
Other Current Liabilities	2.58M	2.06M	14.34M	1.4M	2.17M
Total Current Liabilities	30.94M	27M	32.44M	17.83M	17.8M
Long-Term Debt	-	20.88M	14.85M	-	-
Long-Term Leases	1.12M	245K	2M	1.02M	8K
Other Non Current Liabilities	1K	-	-	-	-1K
Total Liabilities	32.07M	48.12M	49.3M	18.86M	17.8M
Common Stock, Total	5.97M	6.57M	6.57M	9.71M	9.71M
Additional Paid In Capital	439M	507M	507M	656M	656M
Retained Earnings	-319M	-388M	-437M	-491M	-542M
Comprehensive Income and Other	-845K	169K	213K	1.31M	618K
Total Common Equity	125M	126M	76.61M	176M	124M
Minority Interest	-	-	-	-	-
Total Equity	125M	126M	76.61M	176M	124M
Total Liabilities And Equity	157M	174M	126M	195M	142M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	149M	164M	164M	243M	243M
ECS Total Common Shares Outstanding	149M	164M	164M	243M	243M
Book Value / Share	0.84	0.77	0.47	0.73	0.51
Tangible Book Value	59.78M	61.46M	12.28M	113M	60.64M
Tangible Book Value Per Share	0.4	0.37	0.07	0.46	0.25
Total Debt	2.63M	22.32M	18.08M	2.2M	1.02M
Net Debt	-28.98M	-28.37M	9.71M	-73.01M	-32.11M
Debt Equivalent Oper. Leases	6.63M	10.22M	11.22M	12.18M	16.44M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	2.62M	2.94M	4.55M	5.74M	3.88M
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	9.82M	8.58M	6.95M	10.97M	15.03M
Machinery, Total	18.74M	23.53M	24.37M	26.59M	24.76M
Full Time Employees	26	21	18	21	20
Accumulated Allowance for Doubtful Accounts (Supple)	28K	-	-	-	-

Fiscal Period: December	2021 (SEK)	2022 (SEK)	2023 (SEK)	2024 (SEK)	2025 (SEK)
Net Income	-45.39M	-68.66M	-49.73M	-53.18M	-51.89M
Depreciation & Amortization - CF	2.57M	3.64M	3.99M	3.67M	3.39M
Amortization of Goodwill and Intangible Assets - (CF)	754K	832K	502K	460K	332K
Depreciation & Amortization, Total	3.32M	4.47M	4.49M	4.13M	3.72M
Amortization of Deferred Charges, Total - (CF)	3.3M	3.3M	2.02M	1.68M	1.68M
(Gain) Loss From Sale Of Asset	43K	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	-	-	-	-	-
Other Operating Activities, Total	-1.2M	742K	1.92M	-606K	880K
Change In Accounts Receivable	17.2M	-1.99M	4M	-211K	5.71M
Change In Inventories	-1.84M	1.08M	88K	-5M	-2.4M
Change in Other Net Operating Assets	-11.31M	-3.52M	-3.08M	-7.32M	1.33M
Cash from Operations	-35.87M	-64.57M	-40.29M	-60.51M	-40.97M
Capital Expenditure	-5.62M	-3.72M	-730K	-393K	-231K
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-509K	-	-	-	-
Cash from Investing	-6.13M	-3.72M	-730K	-393K	-231K
Long-Term Debt Issued, Total	-	20M	-	-	-
Total Debt Issued	-	20M	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-12.92M	-1.6M	-1.39M	-24.18M	-1.18M
Total Debt Repaid	-12.92M	-1.6M	-1.39M	-24.18M	-1.18M
Issuance of Common Stock	66.66M	74.66M	-	159M	390K
Other Financing Activities, Total	-4.21M	-5.7M	-	-7.42M	-
Cash from Financing	49.53M	87.37M	-1.39M	128M	-789K
Foreign Exchange Rate Adjustments	76K	-13K	82K	93K	-86K
Net Change in Cash	7.6M	19.07M	-42.32M	66.85M	-42.08M
Supplemental Items
Cash Interest Paid	889K	122K	84K	1.72M	74K
Levered Free Cash Flow	-25.13M	-43.83M	-16.4M	-49.13M	-21.96M
Unlevered Free Cash Flow	-24.57M	-43.2M	-15.1M	-48.05M	-21.91M
Change In Net Working Capital	-3.21M	4.63M	-9.16M	20.94M	-5.02M
Net Debt Issued / Repaid	-12.92M	18.4M	-1.39M	-24.18M	-1.18M

Fiscal Period: December	2021 (SEK)	2022 (SEK)	2023 (SEK)	2024 (SEK)	2025 (SEK)
Profitability
Return on Assets	-17.73	-25.73	-20	-20.26	-19.04
Return on Total Capital	-22.7	-30.87	-24.69	-23.81	-21.14
Return On Equity %	-39.2	-54.65	-49.02	-42.04	-34.53
Return on Common Equity	-39.2	-54.65	-49.02	-42.04	-34.53
Margin Analysis
Gross Profit Margin %	58.26	58.13	62.59	67.4	61.45
SG&A Margin	96.82	146.07	133.16	149.24	129.26
EBITDA Margin %	-75.3	-132.95	-88.32	-108.01	-90.58
EBITA Margin %	-77.73	-137.67	-93.43	-113.21	-94.68
EBIT Margin %	-79.04	-139.37	-94.42	-114.22	-95.3
Income From Continuing Operations Margin %	-79.3	-140.27	-97.69	-116.68	-96.27
Net Income Margin %	-79.3	-140.27	-97.69	-116.68	-96.27
Net Avail. For Common Margin %	-79.3	-140.27	-97.69	-116.68	-96.27
Normalized Net Income Margin	-49.9	-87.78	-61.04	-73.15	-60.11
Levered Free Cash Flow Margin	-43.9	-89.53	-32.22	-107.8	-40.74
Unlevered Free Cash Flow Margin	-42.93	-88.26	-29.66	-105.44	-40.65
Asset Turnover
Asset Turnover	0.36	0.3	0.34	0.28	0.32
Fixed Assets Turnover	4.5	3.1	3.1	2.95	4.35
Receivables Turnover (Average Receivables)	2.33	3.2	3.98	3.89	4.88
Inventory Turnover (Average Inventory)	2.09	1.71	1.66	1.05	1.17
Short Term Liquidity
Current Ratio	2.09	3.14	1.2	6.28	3.65
Quick Ratio	1.67	2.53	0.7	5.08	2.54
Operating Cash Flow to Current Liabilities	-1.16	-2.39	-1.24	-3.39	-2.3
Days Sales Outstanding (Average Receivables)	156.54	113.9	91.68	94.09	74.78
Days Outstanding Inventory (Average Inventory)	174.92	213.28	220.54	347.46	312.89
Average Days Payable Outstanding	152.06	133.22	134.68	156.72	147.38
Cash Conversion Cycle (Average Days)	179.4	193.95	177.54	284.82	240.29
Long Term Solvency
Total Debt/Equity	2.11	17.67	23.6	1.25	0.82
Total Debt / Total Capital	2.06	15.02	19.09	1.23	0.82
LT Debt/Equity	0.9	16.72	22.01	0.58	0.01
Long-Term Debt / Total Capital	0.88	14.21	17.8	0.57	0.01
Total Liabilities / Total Assets	20.42	27.59	39.16	9.66	12.54
EBIT / Interest Expense	-50.9	-68.42	-23.01	-30.21	-694.18
EBITDA / Interest Expense	-47.16	-63.94	-20.86	-27.81	-643.88
(EBITDA - Capex) / Interest Expense	-53.48	-67.66	-21.21	-28.04	-647
Total Debt / EBITDA	-0.06	-0.35	-0.41	-0.05	-0.02
Net Debt / EBITDA	0.69	0.45	-0.22	1.52	0.67
Total Debt / (EBITDA - Capex)	-0.06	-0.33	-0.41	-0.05	-0.02
Net Debt / (EBITDA - Capex)	0.61	0.42	-0.22	1.51	0.67
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-48.54	-14.49	4	-10.47	18.27
Gross Profit, 1 Yr. Growth %	-56.09	-14.69	11.98	-3.59	7.83
EBITDA, 1 Yr. Growth %	372.54	50.97	-30.92	9.49	-0.81
EBITA, 1 Yr. Growth %	351.71	51.45	-29.42	8.48	-1.32
EBIT, 1 Yr. Growth %	275.12	50.77	-29.55	8.31	-1.32
Earnings From Cont. Operations, 1 Yr. Growth %	243.34	51.25	-27.57	6.94	-2.42
Net Income, 1 Yr. Growth %	243.34	51.25	-27.57	6.94	-2.42
Normalized Net Income, 1 Yr. Growth %	249.87	50.43	-27.68	7.28	-2.81
Diluted EPS Before Extra, 1 Yr. Growth %	234.44	43.73	-31.96	-8.86	-22.52
Accounts Receivable, 1 Yr. Growth %	-50.22	-12.81	-20.29	6.59	-17.31
Inventory, 1 Yr. Growth %	18.92	-7.46	-0.1	45.3	13.21
Net Property, Plant and Equip., 1 Yr. Growth %	47.72	8.19	0.51	-12.65	-28.02
Total Assets, 1 Yr. Growth %	-3.08	11.06	-27.81	55.05	-27.27
Tangible Book Value, 1 Yr. Growth %	45.21	2.82	-80.02	815.99	-46.1
Common Equity, 1 Yr. Growth %	17.18	1.06	-39.34	130.22	-29.59
Cash From Operations, 1 Yr. Growth %	236.73	80	-37.6	50.19	-32.29
Capital Expenditures, 1 Yr. Growth %	16.27	-33.91	-80.36	-46.16	-41.22
Levered Free Cash Flow, 1 Yr. Growth %	185.5	74.41	-62.57	199.53	-55.3
Unlevered Free Cash Flow, 1 Yr. Growth %	196.1	75.82	-65.06	218.3	-54.4
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-3.37	-33.67	-5.7	-3.51	2.9
Gross Profit, 2 Yr. CAGR %	-13.81	-38.8	-2.26	3.9	1.96
EBITDA, 2 Yr. CAGR %	5.61	167.1	2.13	-13.03	4.21
EBITA, 2 Yr. CAGR %	6.17	161.56	3.39	-12.5	3.59
EBIT, 2 Yr. CAGR %	4.22	137.82	3.06	-12.65	3.38
Earnings From Cont. Operations, 2 Yr. CAGR %	5.25	127.88	4.67	-11.99	2.15
Net Income, 2 Yr. CAGR %	5.25	127.88	4.67	-11.99	2.15
Normalized Net Income, 2 Yr. CAGR %	4.39	129.41	4.3	-11.92	2.11
Diluted EPS Before Extra, 2 Yr. CAGR %	3.87	119.24	-1.11	-21.25	-15.97
Accounts Receivable, 2 Yr. CAGR %	3.33	-34.12	-16.63	-7.82	-6.12
Inventory, 2 Yr. CAGR %	33.32	4.9	-3.85	20.48	28.25
Net Property, Plant and Equip., 2 Yr. CAGR %	49.54	26.42	4.28	-6.3	-20.7
Total Assets, 2 Yr. CAGR %	3.11	3.75	-10.46	5.8	6.19
Tangible Book Value, 2 Yr. CAGR %	7.73	22.19	-54.67	35.29	122.2
Common Equity, 2 Yr. CAGR %	2.39	8.82	-21.71	18.17	27.31
Cash From Operations, 2 Yr. CAGR %	-2.3	146.2	5.98	-3.19	0.85
Capital Expenditures, 2 Yr. CAGR %	154.84	-12.34	-63.97	-67.48	-43.75
Levered Free Cash Flow, 2 Yr. CAGR %	5.12	123.15	-19.21	5.88	15.71
Unlevered Free Cash Flow, 2 Yr. CAGR %	4.45	128.16	-21.62	5.46	20.48
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.89	-7.23	-22.94	-7.32	3.27
Gross Profit, 3 Yr. CAGR %	-3.23	-14.1	-25.14	-2.7	5.2
EBITDA, 3 Yr. CAGR %	4.61	18.97	70.18	4.52	-9.13
EBITA, 3 Yr. CAGR %	5	19.51	69.02	5.06	-8.85
EBIT, 3 Yr. CAGR %	3.69	17.87	58.54	4.78	-9.02
Earnings From Cont. Operations, 3 Yr. CAGR %	2.16	18.77	55.52	5.42	-8.91
Net Income, 3 Yr. CAGR %	2.16	18.77	55.52	5.42	-8.91
Normalized Net Income, 3 Yr. CAGR %	2.73	17.91	56.14	5.29	-8.98
Diluted EPS Before Extra, 3 Yr. CAGR %	-11.54	15.75	48.44	-3.76	-21.68
Accounts Receivable, 3 Yr. CAGR %	16.04	-2.36	-29.8	-9.51	-11.1
Inventory, 3 Yr. CAGR %	30.85	18.04	3.21	10.33	18
Net Property, Plant and Equip., 3 Yr. CAGR %	49.49	34.25	17.11	-1.7	-14.18
Total Assets, 3 Yr. CAGR %	-5.34	5.7	-8.06	7.52	-6.63
Tangible Book Value, 3 Yr. CAGR %	-12.74	6.07	-33.18	23.46	-0.45
Common Equity, 3 Yr. CAGR %	-7.84	1.94	-10.44	12.17	-0.56
Cash From Operations, 3 Yr. CAGR %	7.6	19.77	55.8	19.04	-14.07
Capital Expenditures, 3 Yr. CAGR %	121.15	62.51	-46.76	-58.81	-60.39
Levered Free Cash Flow, 3 Yr. CAGR %	28.65	24.44	23.06	25.04	-20.57
Unlevered Free Cash Flow, 3 Yr. CAGR %	30.91	24.25	22.07	25.05	-20.25
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.43	-3.81	-0.64	-5.76	-13.49
Gross Profit, 5 Yr. CAGR %	8.45	-4.77	-2.84	-7.31	-15.29
EBITDA, 5 Yr. CAGR %	0.35	19.25	3.61	4.96	39.87
EBITA, 5 Yr. CAGR %	0.78	19.54	4.35	5.5	38.96
EBIT, 5 Yr. CAGR %	0.57	17.69	3.44	4.56	33.62
Earnings From Cont. Operations, 5 Yr. CAGR %	0.17	16.9	3.15	5.35	31.45
Net Income, 5 Yr. CAGR %	0.17	16.9	3.15	5.35	31.45
Normalized Net Income, 5 Yr. CAGR %	0.47	17.37	3.36	4.93	31.74
Diluted EPS Before Extra, 5 Yr. CAGR %	-14.92	5.16	-7.5	-0.78	18.22
Accounts Receivable, 5 Yr. CAGR %	11.4	1.04	1.67	-4.58	-21.14
Inventory, 5 Yr. CAGR %	12.23	33.71	15.68	19.01	12.58
Net Property, Plant and Equip., 5 Yr. CAGR %	28.21	27.48	29.43	16.26	0.2
Total Assets, 5 Yr. CAGR %	-0.7	5.44	-7.42	5.74	-2.61
Tangible Book Value, 5 Yr. CAGR %	-2.32	9.8	-32.85	16.91	8.05
Common Equity, 5 Yr. CAGR %	-2.48	2.74	-13.66	8.15	3.09
Cash From Operations, 5 Yr. CAGR %	-1.37	23.42	6.95	10	30.92
Capital Expenditures, 5 Yr. CAGR %	24.27	24.06	7.02	-14.62	-45.57
Levered Free Cash Flow, 5 Yr. CAGR %	-7.61	25.31	6.81	16.66	20.07
Unlevered Free Cash Flow, 5 Yr. CAGR %	-7.67	25.56	6.63	16.36	21.43